Varian to Discuss Agreement to Acquire Sirtex | Varian

Varian to Discuss Agreement to Acquire Sirtex

PALO ALTO, Calif., Jan. 30, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced that it will webcast a conference call to discuss the details of the agreement, also announced today, to acquire all the outstanding shares of Sirtex Medical Limited (ASX: SRX) ("Sirtex").  Sirtex is an Australia-based global life sciences company focused on interventional oncology therapies, that is listed on the Australian Securities Exchange.

The conference call and webcast will start at 9:00 a.m. ET on Tuesday, January 30, 2018.  To access the teleconference call and replay:

Teleconference:  Access from within the U.S. by dialing 1-877-869-3847, and from outside the U.S. by dialing 1-201-689-8261.

Webcast:  The live webcast and replay will be available on the Varian Investor Relations website at

About Varian

Varian is a leader in developing and delivering cancer care solutions, and is focused on creating a world without fear of cancer. Headquartered in Palo Alto, California, Varian employs approximately 6,500 people around the world. For more information, visit and follow @VarianMedSys on Twitter.

Investor Relations Contact

J. Michael Bruff
Vice President, Investor Relations
+1 (650) 424-5163

Press Contact

Mark Plungy
Director, Public Relations
+1 (650) 424-5630